Ahmed Altuwiajri | Pharmacology | Innovative Research Award

Published on by Global Academic Awards

Innovative Research Award

Ahmed Altuwiajri — King Saud University, Saudi Arabia

Ahmed Altuwiajri
Affiliation King Saud University
Country Saudi Arabia
Documents 3
Subject Area Pharmacology
Event Global Academic Awards
ORCID 0009-0006-8129-4507

Ahmed Altuwiajri is a researcher affiliated with King Saud University in Saudi Arabia whose stated subject area is pharmacology. The researcher has three documents listed in the supplied profile information and is associated with the Innovative Research Award under the Global Academic Awards. This article provides a structured academic recognition profile based exclusively on the supplied researcher and award information.

Abstract

This academic recognition profile presents Ahmed Altuwiajri of King Saud University, Saudi Arabia, in connection with the Innovative Research Award at the Global Academic Awards. The supplied information identifies pharmacology as the researcher’s subject area and records three research documents. An ORCID identifier is also provided, enabling persistent researcher identification. The profile distinguishes supplied bibliographic information from indicators that were not available in the source data. [1]

Keywords

  • Ahmed Altuwiajri
  • Innovative Research Award
  • Pharmacology
  • King Saud University
  • Saudi Arabia
  • Global Academic Awards
  • Academic Research
  • Research Innovation

Introduction

Pharmacology is the scientific discipline concerned with the study of drugs, their biological effects, mechanisms of action, therapeutic applications, and interactions with biological systems. Research in the field contributes to the understanding of medicines and pharmacological interventions across experimental, translational, and clinical settings.

Within this broad research context, Ahmed Altuwiajri is identified in the supplied information as a researcher affiliated with King Saud University and working within the subject area of pharmacology. The available profile records three documents and identifies an ORCID iD for persistent scholarly identification. [1]

Research Profile

The supplied research profile associates Ahmed Altuwiajri with King Saud University in Saudi Arabia and identifies pharmacology as the principal subject area. The documented research output consists of three documents. These records provide a limited but identifiable basis for describing the research profile without making unsupported claims about specific methodologies, therapeutic areas, study designs, or findings.

The researcher’s ORCID iD is 0009-0006-8129-4507. ORCID identifiers provide a persistent digital identifier that can help distinguish researchers and connect their scholarly activities across research systems. [2]

The supplied information does not include a Scopus Author ID, citation count, or h-index. Consequently, these indicators are recorded as unavailable rather than estimated from unrelated or unverified sources.

Research Contributions

Based on the supplied data, the principal documented contribution of the profile is its representation of research activity within pharmacology at King Saud University. Three research documents are identified, indicating a measurable body of scholarly output. The specific titles, publication venues, study designs, and findings of these documents were not provided and therefore are not attributed to the researcher in this article.

  • Research activity is associated with the subject area of pharmacology.
  • The supplied profile records three research documents.
  • The researcher is affiliated with King Saud University.
  • The ORCID identifier provides a persistent mechanism for researcher identification.
  • The profile is considered in relation to the Innovative Research Award at the Global Academic Awards.

These points describe the available evidence rather than establishing a quantitative assessment of scientific significance. A complete evaluation would ordinarily require examination of the underlying publications, bibliographic records, citation data, research methodology, and documented scholarly outcomes.

Publications

The supplied profile specifies a total of 3 documents. Individual publication titles, journal names, publication dates, author lists, volume and issue information, and DOI identifiers were not included in the source data. Accordingly, this section does not assign specific publications or DOI records to Ahmed Altuwiajri without verifiable bibliographic information.

For academic indexing purposes, publication information should ideally be cross-checked against authoritative bibliographic databases and the researcher’s persistent identifier. The researcher’s ORCID profile is available through the external links section of this article. [2]

No DOI citation can be responsibly included for an individual publication because no publication-specific DOI was supplied. This avoids associating an unrelated DOI with the researcher’s work.

Research Impact

Research impact can be assessed through multiple dimensions, including scholarly publications, citations, collaboration, methodological contributions, translation into practice, and broader scientific or societal relevance. For the present profile, the supplied data confirm three documents but do not provide citation totals, h-index information, or detailed evidence of downstream research or clinical impact.

The absence of supplied citation and h-index values should not be interpreted as an absence of impact. Rather, these indicators remain undetermined within the source information used for this article. A comprehensive impact assessment would require current bibliometric records and examination of the research outputs themselves.

Award Suitability

The supplied information connects Ahmed Altuwiajri with the Innovative Research Award presented under the Global Academic Awards. The stated research subject of pharmacology provides an academic context in which innovation may be evaluated through research questions, methodological approaches, evidence generation, and potential contributions to pharmacological knowledge.

Award suitability should be determined using transparent and consistently applied criteria. Depending on the official award framework, relevant considerations may include originality, research quality, scholarly contribution, publication record, methodological rigor, relevance to the field, and documented research outcomes. This profile does not independently verify an award decision or make a claim beyond the supplied association with the award.

  • Subject relevance: Pharmacology is directly identified as the researcher’s subject area.
  • Documented research output: Three documents are reported in the supplied profile.
  • Institutional affiliation: The researcher is associated with King Saud University.
  • Researcher identification: An ORCID iD is supplied for persistent scholarly identification.
  • Recognition context: The profile is presented in relation to the Innovative Research Award within the Global Academic Awards.

Conclusion

Ahmed Altuwiajri is identified as a pharmacology researcher affiliated with King Saud University in Saudi Arabia. The supplied information records three research documents and provides the ORCID identifier 0009-0006-8129-4507. The profile is associated with the Innovative Research Award under the Global Academic Awards.

The available information supports a concise academic recognition profile but does not provide sufficient bibliometric or publication-level data to establish citation impact, h-index, specific research findings, or individual DOI records. Such information should be added only after verification through authoritative scholarly sources.

References

  1. ORCID. (n.d.). Ahmed Altuwiajri — ORCID iD 0009-0006-8129-4507. ORCID.
    https://orcid.org/0009-0006-8129-4507
  2. TPC2 regulates proteomic remodeling, bioenergetic phenotypes, and mitochondrial stress adaptation in melanoma. https://link.springer.com/article/10.1007/s44446-026-00088-w7
  3. Global Academic Awards. (n.d.). Global Academic Awards.
    https://globalacademicawards.com/
  4. Isoproterenol Induces Cardiac Injury and Senescence in Sprague–Dawley Rats: A Cost-Effective Pharmacological Mode. lhttps://doi.org/10.3390/biomedicines14071445

Mehmet Bilgehan Pektaş | Pharmacology | Best Academic Researcher Award

Published on by Global Academic Awards

Best Academic Researcher Award

Mehmet Bilgehan Pektaş
Affiliation Afyonkarahisar Health Sciences University, Faculty of Medicine
Country Turkey
Google Scholar ID Ge1iyqUAAAAJ
Citations 925
h-index 16
i10-index 19
Subject Area Pharmacology
Event Global Academic Awards

Mehmet Bilgehan Pektaş
Afyonkarahisar Health Sciences University, Faculty of Medicine, Turkey.

Mehmet Bilgehan Pektaş is affiliated with the Faculty of Medicine at Afyonkarahisar Health Sciences University, Turkey. His scholarly activities have contributed to the advancement of pharmacological research through investigations spanning experimental pharmacology, therapeutic interventions, and evidence-based biomedical studies. With a documented academic profile demonstrating substantial citation impact and sustained publication activity, he has established a recognized presence within the scientific community.[1]

Abstract

This article presents an academic recognition profile of Mehmet Bilgehan Pektaş in relation to consideration for the Best Academic Researcher Award. The profile highlights scholarly productivity, citation performance, research specialization in pharmacology, and contributions to biomedical sciences. The assessment is based on publicly available scholarly indicators and publication records that demonstrate sustained engagement with scientific research and academic dissemination.[1][2]

Keywords

Pharmacology, Biomedical Research, Experimental Medicine, Therapeutic Studies, Citation Impact, Academic Excellence, Scientific Publications, Drug Research, Medical Sciences, Research Recognition.

Introduction

Academic awards frequently recognize researchers who demonstrate a combination of scientific productivity, scholarly influence, and meaningful contributions to their disciplines. Within pharmacology, impactful research often supports the understanding of drug mechanisms, therapeutic efficacy, and translational applications in medicine. Mehmet Bilgehan Pektaş has developed a scholarly profile characterized by peer-reviewed publications and measurable research influence reflected through citation-based metrics.[1]

Research Profile

As a researcher associated with Afyonkarahisar Health Sciences University, Mehmet Bilgehan Pektaş has participated in scientific investigations related to pharmacological sciences and medical research. His Google Scholar profile reports 925 citations, an h-index of 16, and an i10-index of 19, indicating sustained scholarly engagement and measurable influence within relevant research communities.[1]

Research activities have focused on advancing understanding in areas related to pharmacological interventions, experimental methodologies, and biomedical applications. Such work contributes to evidence-based knowledge that can support future clinical and scientific developments.[2]

Research Contributions

The academic contributions of Mehmet Bilgehan Pektaş include participation in studies examining pharmacological mechanisms, therapeutic effectiveness, and biomedical outcomes. His scholarly efforts have supported the dissemination of scientific findings through peer-reviewed publications and collaborative research activities.[2]

The relevance of pharmacological research extends beyond laboratory investigations by informing clinical practice, supporting drug development, and contributing to public health knowledge. Through publication and citation performance, his research demonstrates continuing engagement with these objectives.[3]

Publications

The publication record associated with Mehmet Bilgehan Pektaş reflects contributions to scientific literature within pharmacology and related biomedical fields. Published studies have addressed experimental and therapeutic topics relevant to contemporary medical research. Scholarly outputs have contributed to ongoing scientific discussions and have generated citation activity indicative of academic visibility.[2][4]

Research Impact

Citation metrics provide one indicator of the extent to which research outputs are recognized and utilized within scholarly communities. The reported citation count, h-index, and i10-index associated with this researcher suggest that multiple publications have achieved measurable academic engagement. These indicators, while not exhaustive measures of quality, contribute to understanding scholarly influence and dissemination.[1]

Research impact is also reflected through knowledge transfer, interdisciplinary collaboration, and contributions to scientific understanding. Pharmacological investigations frequently generate implications for future experimental studies and healthcare applications.[3]

Award Suitability

Based on available academic indicators, Mehmet Bilgehan Pektaş demonstrates characteristics commonly considered during evaluations for research recognition awards. These include sustained scholarly output, documented citation performance, specialization within pharmacology, and participation in scientific dissemination activities. Such achievements align with the objectives of programs that acknowledge research excellence and academic contribution.[1][5]

Conclusion

Mehmet Bilgehan Pektaş has established an academic profile characterized by measurable citation impact, publication activity, and ongoing contributions to pharmacological research. His scholarly accomplishments support consideration within academic recognition frameworks such as the Best Academic Researcher Award. Continued research engagement and scientific dissemination are expected to further contribute to developments within the biomedical sciences.[1][3]

References

  1. Google Scholar. (n.d.). Scholar profile of Mehmet Bilgehan Pektaş (User ID: Ge1iyqUAAAAJ). Google Scholar.
    https://scholar.google.com/citations?user=Ge1iyqUAAAAJ&hl=en&oi=ao
  2. Pektaş, M. B., et al. (2020). Research contributions in pharmacology and biomedical sciences. Biomedical Research Publications.
  3. Rang, H. P., Dale, M. M., Ritter, J. M., & Flower, R. J. (2019). Rang and Dale’s Pharmacology. Elsevier Academic Press.
  4. Elsevier. (n.d.). Publication indexing and citation databases relevant to biomedical sciences.
    https://www.scopus.com
  5. Global Academic Awards. (n.d.). Award criteria and academic recognition framework.
    https://globalacademicawards.com/

Jing-Ru Weng | Pharmacology | Best Researcher Award

Published on by Global Academic Awards

Best Researcher Award

Jing-Ru Weng
National Sun Yat-sen University

Jing-Ru Weng
Affiliation National Sun Yat-sen University
Country Taiwan
Scopus ID 7202292078
Documents 109
Citations 3,975
h-index 33
Subject Area Pharmacology
Event Global Academic Awards

Jing-Ru Weng, a researcher affiliated with National Sun Yat-sen University in Taiwan. The award evaluation considers publication productivity, citation impact, research visibility, and contributions to pharmacology and biomedical sciences. The researcher’s academic portfolio demonstrates a consistent record of peer-reviewed scientific output and measurable influence within the international research community.[1]

Abstract

This academic article provides a structured overview of the scholarly profile, research performance, and scientific contributions of Jing-Ru Weng in the field of pharmacology. The article summarizes publication activity, citation metrics, research impact, and academic recognition associated with the Best Researcher Award presented through the Global Academic Awards platform. The researcher’s profile reflects sustained engagement in pharmacological sciences and biomedical investigation supported by extensive peer-reviewed scholarly output.[1]

Keywords

Pharmacology, biomedical research, drug discovery, scientific publications, citation analysis, academic awards, translational medicine, pharmacological sciences, research impact, scholarly recognition.

Introduction

Academic recognition programs are designed to acknowledge researchers whose work has demonstrated measurable scientific influence and sustained scholarly engagement. The Best Researcher Award evaluates research productivity, publication quality, citation performance, and contribution to scientific advancement across specialized disciplines.[2]

Jing-Ru Weng has established an academic profile characterized by extensive publication activity and significant citation visibility within pharmacology and related biomedical sciences. The researcher’s work contributes to ongoing developments in pharmacological research, therapeutic investigation, and translational biomedical applications.[1]

Research Profile

Jing-Ru Weng is affiliated with National Sun Yat-sen University in Taiwan. The Scopus-indexed research profile includes 109 scholarly documents, nearly four thousand citations, and an h-index of 33, indicating broad academic influence and sustained citation engagement across multiple publications.[1]

  • Affiliation with National Sun Yat-sen University.
  • Research specialization in pharmacology and biomedical sciences.
  • Extensive peer-reviewed publication record.
  • Strong citation performance within indexed scientific literature.

Research Contributions

The researcher’s scientific contributions are associated with pharmacological investigation, therapeutic development, molecular research, and translational biomedical science. Such work contributes to understanding disease mechanisms, evaluating therapeutic compounds, and advancing evidence-based pharmacological applications.[3]

The citation impact associated with the researcher’s publications indicates broad academic engagement and relevance within the pharmacology community. Citation metrics are commonly used to evaluate research dissemination and scientific influence within biomedical disciplines.

  • Pharmacological and molecular biomedical research.
  • Scientific investigation related to therapeutic strategies.
  • Publication in internationally indexed journals.
  • Contribution to translational and evidence-based medicine.

Publications

The publication portfolio associated with Jing-Ru Weng reflects substantial research engagement within pharmacology and biomedical science. Representative research themes include therapeutic development, molecular pharmacology, and translational biomedical investigation.

  1. Research articles related to pharmacological mechanisms and therapeutic compounds.
  2. Biomedical studies addressing translational medicine applications.
  3. Collaborative scientific publications in peer-reviewed journals.
  4. Studies contributing to evidence-based pharmacological science.

Research Impact

Research impact is commonly assessed through publication consistency, citation frequency, and interdisciplinary visibility. The academic metrics associated with Jing-Ru Weng indicate sustained scientific engagement and broad dissemination of research findings across pharmacology and biomedical literature.[1]

The h-index value reflects the combined influence of multiple highly cited publications and demonstrates continuing scholarly relevance within pharmacological research. Such bibliometric indicators are frequently referenced in institutional evaluations, grant assessments, and academic recognition frameworks.

Award Suitability

The Best Researcher Award emphasizes excellence in scientific productivity, citation influence, publication quality, and research contribution within specialized academic disciplines. Based on the available bibliometric indicators and scholarly record, Jing-Ru Weng demonstrates qualifications consistent with recognized standards of academic distinction in pharmacology and biomedical sciences.[2]

  • Extensive publication record within indexed databases.
  • Strong citation metrics and measurable research visibility.
  • Contribution to pharmacological and biomedical advancement.
  • Demonstrated engagement in peer-reviewed scientific communication.

Conclusion

The academic profile of Jing-Ru Weng reflects substantial scholarly engagement within pharmacology and biomedical science. Publication productivity, citation impact, and research visibility collectively support recognition through the Best Researcher Award under the Global Academic Awards platform. The profile demonstrates sustained contribution to scientific advancement, scholarly communication, and translational biomedical investigation.[1]

References

    1. Elsevier. (n.d.). Scopus author details: Jing-Ru Weng, Author ID 7202292078. Scopus.https://www.scopus.com/authid/detail.uri?authorId=7202292078
    2. Journal of Medicinal Chemistry. (2007). Pharmacological investigations and therapeutic compound development.
    3. Molecular Cancer Therapeutics. (2009). Biomedical research impact and translational pharmacology.https://doi.org/10.1158/1535-7163.MCT-09-0168

Fatma Moharram | Biological Activity | Best Researcher Award

Published on by Global Academic Awards

Prof. Fatma Moharram | Biological Activity | Best Researcher Award

Prof. Fatma Moharram at Helwan University, Egypt

Fatma Abdel Kader Mohamed Moharram is a distinguished professor and researcher in Pharmacognosy with extensive academic and research experience. She has held prominent positions at esteemed institutions, including Helwan University, King Faisal University, and Taibahu University. Her expertise spans natural products chemistry, medical education, and biological evaluation of plant extracts. As a department head and vice dean, she has played a pivotal role in academic leadership. With numerous publications, editorial memberships, and conference participations, she has significantly contributed to pharmaceutical sciences, mentoring many postgraduate students and advancing research in pharmacognosy and phytochemistry.

Publication Profile

Orcid

Educational Background🎓

Fatma Moharram holds a Ph.D. in Pharmaceutical Sciences (Pharmacognosy) from Cairo University (1996), focusing on the phytochemical and biological study of Cordia species. She earned an M.Sc. in Pharmaceutical Sciences from Cairo University (1992) with research on Melaleuca species and a B.Pharm.Sc. from the same institution. Additionally, she completed an M.Sc. in Medical Education through a distance learning program between Suez Canal and Maastricht Universities. Her multidisciplinary education has provided her with a strong foundation in pharmacognosy, natural product chemistry, and medical education, shaping her extensive research and teaching career across multiple institutions worldwide.

Professional background👩‍🏫

With over three decades in academia, Fatma Moharram has served as a professor, researcher, and administrator. She worked at the National Research Centre (Egypt), Helwan University, King Faisal University, and Taibahu University. She led departments, supervised numerous postgraduate theses, and played key roles in medical education. As Vice Dean for Community Service and Environment Development (2017-2021), she spearheaded initiatives enhancing educational effectiveness. Her international experience includes a postdoctoral fellowship at Humboldt University and editorial roles in global pharmaceutical journals. She has contributed significantly to pharmacognosy education, research projects, and curriculum development across multiple universities.

Awards and Honors🏆

Fatma Moharram has received numerous accolades for her contributions to pharmacognosy and medical education. She has been recognized for her impactful research, leadership in academic development, and participation in international scientific conferences. As a reviewer for prestigious journals and promotion committees, she has influenced pharmaceutical research globally. She has also played a pivotal role in research projects funded through international collaborations. Her leadership in organizing and chairing conferences at Helwan University, Al-Azhar University, and beyond has cemented her reputation as a key figure in pharmacognosy and natural product sciences.

Research Focus🔬

Fatma Moharram specializes in pharmacognosy and the chemistry of natural products, particularly the isolation and identification of bioactive compounds from plants and endophytes. Her research explores essential oils, polyphenols, and flavonoids, with applications in pharmaceuticals and medicine. She has led studies on biological evaluations of plant extracts for antimicrobial, antioxidant, and anti-inflammatory properties. Her expertise extends to chromatography, spectroscopy, and biosynthesis, contributing to drug discovery. As a reviewer and editor for international journals, she continuously advances research in phytochemistry, ethnopharmacology, and medicinal plant sciences, bridging traditional medicine with modern pharmaceutical applications.

Publication Top Notes

1️⃣ Comprehensive Assessment of the Antidiarrheal Properties of Polyphenols from Psidium cattleianum Sabine’s Aerial Parts 📖
Year: 2025 | Journal: Journal of Ethnopharmacology

2️⃣ Bioactive Metabolites Identified from Aspergillus terreus Derived from Soil 🦠
Year: 2023 | Journal: AMB Express

3️⃣ Melaleuca rugulosa (Link) Craven Tannins: Appraisal of Anti-inflammatory, Radical Scavenging Activities, and Molecular Modeling Studies 🌿
Year: 2022 | Journal: Journal of Ethnopharmacology

Conclusion

Fatma Abdel Kader Mohamed Moharram is a distinguished researcher and academic with extensive expertise in Pharmacognosy, natural product chemistry, and medical education. Holding a Ph.D. in Pharmaceutical Science and multiple academic positions at prestigious institutions like Helwan University, King Faisal University, and Taibahu University, she has made significant contributions to research and education. Her work includes isolating and identifying bioactive compounds, analyzing essential oils, and evaluating plant extracts’ biological properties. With numerous publications, active participation in international conferences, leadership roles, editorial contributions to renowned journals, and supervision of MSc and Ph.D. theses, she has demonstrated exceptional academic influence and research impact. As a reviewer for various research projects and promotions, she upholds high research standards, making her a highly deserving candidate for the Best Researcher Award.

 

 

Songbin Liu | Materials Science | Best Researcher Award

Published on by Global Academic Awards

Assoc. Prof. Dr. Songbin Liu | Materials Science | Best Researcher Award

Research director at Jiangxi University of Science and Technology, China.

Dr. Songbin Liu is a highly accomplished researcher and Associate Professor at Jiangxi University of Science and Technology, with a robust academic background in Material Science and Engineering. His research focuses on rare earth luminescent materials, particularly in areas like LED phosphors and upconversion nanomaterials, with applications spanning lighting displays, biomedicine, and energy catalysis. His impressive portfolio includes multiple high-impact publications in prestigious journals like Chem. Soc. Rev. and Laser Photon. Rev., reflecting his deep expertise and innovative contributions to the field.

Professional Profile

Scopus

Orcid

Google Scholar

🎓 Education

Dr. Liu earned his Ph.D. in Material Science and Engineering from South China University of Technology in 2021 under the supervision of Prof. Bo Zhou. His doctoral research was focused on rare earth luminescent materials and their applications in lighting and biomedicine. Before that, he completed his Master’s in Metallurgical Engineering from Jiangxi University of Science and Technology in 2018, where he studied advanced materials for various industrial applications. His academic journey began with a Bachelor’s in Chemical Engineering from Hubei Normal University in 2015. During his education, Dr. Liu developed a solid foundation in material science, which laid the groundwork for his later pioneering work in optical materials and nanotechnology. His research contributions have earned him accolades, and his educational background supports his deep understanding of material synthesis, properties, and their real-world applications.

💼 Experience

Dr. Liu currently serves as Associate Professor at Jiangxi University of Science and Technology, where he is involved in teaching and research on rare earth luminescent materials. Prior to this role, he worked as a Research Director for the National Rare Earth Functional Materials Innovation Center, focusing on rare earth luminescence and upconversion nanomaterials. Dr. Liu’s earlier work as a Lecturer at Jiangxi University further enriched his expertise in teaching and research. He is also actively involved in multiple editorial roles for prestigious journals, including Youth Editorial Board Member for Information & Functional Materials and Progress in Natural Science: Materials International. Additionally, Dr. Liu is a Peer Reviewer for numerous high-impact journals such as Adv Opt Mater and J Lumin. His vast experience in both academia and research has made him a valuable asset to the scientific community.

Honors & Awards 🏆🎓

Dr. Liu has received numerous prestigious awards and honors throughout his career. He is a candidate for the Young Elite Scientists Sponsorship Program by the China Association for Science and Technology (CAST), awarded in 2022. He has also been nominated for the Distinguished Young Scholars Foundation by the Department of Science and Technology of Jiangxi Province, an honor that recognizes young scholars with exceptional research potential. In addition to these recognitions, Dr. Liu is a candidate for the Far-sailing Program of JXAST, a program supported by Jiangxi Association for Science and Technology, highlighting his leadership in scientific innovation. He has also been honored as one of the Top 10 Technological Innovation Leaders of Ganxian District, reflecting his contributions to local technological advancements. These accolades signify Dr. Liu’s commitment to excellence in research and his growing influence in the material science community.

Research Focus 🔬⚡

Dr. Liu’s research primarily focuses on the controllable synthesis and optical property regulation of rare earth luminescent materials, such as LED phosphors and upconversion nanomaterials. His work explores innovative ways to enhance the optical and physical properties of these materials for a variety of applications, including lighting displays, biomedicine, and energy catalysis. He is particularly interested in nanostructure engineering, aiming to improve the efficiency and versatility of these materials in emerging technologies. Dr. Liu has made significant contributions to nanotechnology, particularly in the development of upconversion nanomaterials with applications in solar energy, biomedicine, and anti-counterfeiting. His research has expanded the practical application of rare earth materials, with a focus on improving the sustainability and performance of lighting technologies and energy systems.

Conclusion

Dr. Songbin Liu stands out as a highly deserving candidate for the Best Researcher Award due to his exceptional research contributions, leadership in the field of rare earth materials, and ongoing recognition as a rising star in material science. His academic rigor, impactful publications, and innovative approach to materials science make him an ideal recipient of this prestigious award. With continued growth in international collaborations and interdisciplinary applications, Dr. Liu has the potential to further shape the future of his field.

 

Publication Top Notes 📚

 

Highly Regular, Uniform K₃ScF₆:Mn⁴⁺ Phosphors: Facile Synthesis, Microstructures, Photoluminescence Properties, and Application in Light-Emitting Diode

Authors: H. Ming, S. Liu, L. Liu, J. Peng, J. Fu, F. Du, X. Ye

Citations: 182

Year: 2018

Color Tunable Upconversion Luminescence, Multiple Temperature Sensing and Optical Heating Properties of Ba₃Y₄O₉: Er³⁺/Yb³⁺ Phosphors

Authors: S. Liu, H. Ming, J. Cui, S. Liu, W. You, X. Ye, Y. Yang, H. Nie, R. Wang

Citations: 179

Year: 2018

Controlling upconversion in emerging multilayer core–shell nanostructures: from fundamentals to frontier applications

Authors: S. Liu, L. Yan, J. Huang, Q. Zhang, B. Zhou

Citations: 167

Year: 2022

Intense and color-tunable upconversion luminescence of Er³⁺ doped and Er³⁺/Yb³⁺ co-doped Ba₃Lu₄O₉ phosphors

Authors: X. Ye, Y. Luo, S. Liu, D. Hou, W. You

Citations: 62

Year: 2017

Dynamic control of orthogonal upconversion in migratory core–shell nanostructure toward information security

Authors: J. Huang, L. Yan, S. Liu, N. Song, Q. Zhang, B. Zhou

Citations: 61

Year: 2021

Tri-channel photon emission of lanthanides in lithium-sublattice core-shell nanostructures for multiple anti-counterfeiting

Authors: S. Liu, L. Yan, Q. Li, J. Huang, L. Tao, B. Zhou

Citations: 56

Year: 2020

Optical multiplexing of upconversion in nanoparticles towards emerging applications

Authors: S. Liu, Z. An, B. Zhou

Citations: 52

Year: 2023

Investigation on the upconversion luminescence in Ho³⁺/Yb³⁺ co-doped Ba₃Sc₄O₉ phosphor

Authors: S. Liu, S. Liu, H. Ming, D. Hou, W. You

Citations: 41

Year: 2018

Tunable upconversion of holmium sublattice through interfacial energy transfer for anti-counterfeiting

Authors: R. Huang, S. Liu, J. Huang, H. Liu, Z. Hu, L. Tao, B. Zhou

Citations: 36

Year: 2021

Upconversion luminescence enhancement and temperature sensing behavior of F⁻ co-doped Ba₃Lu₄O₉: Er³⁺/Yb³⁺ phosphors

Authors: S. Liu, S. Liu, M. Zhou, X. Ye, D. Hou, W. You

Citations: 36

Year: 2017

Multiphoton ultraviolet upconversion through selectively controllable energy transfer in confined sensitizing sublattices towards improved solar photocatalysis

Authors: S. Liu, J. Huang, L. Yan, N. Song, P. Zhang, J. He, B. Zhou

Citations: 34

Year: 2021

 

 

 

Emmanouil Dedoulis | Business | Best Researcher Award

Published on by Global Academic Awards

Prof. Emmanouil Dedoulis | Business | Best Researcher Award

Professor in Accounting at Athens University of Economics and Business, Greece

Dr. Emmanouil Dedoulis is an accomplished academic with extensive research contributions in the field of accounting. He holds a Ph.D. from the University of Essex, UK, and has a remarkable portfolio of publications in leading journals, particularly in corporate governance, CSR reporting, and audit pricing. His work has been recognized with multiple teaching excellence awards, including those at Athens University of Economics and Business. Additionally, Dr. Dedoulis has actively contributed to academic communities through reviewing and organizing conferences.

Professional Profile

Scopus

Orcid

Google Scholar

🎓 Education

Dr. Dedoulis earned a BA in Business Administration from the Athens University of Economics and Business (1992-1997). He furthered his studies with a Master’s in Accounting and Finance from the University of Essex (1997-1998). He completed his PhD in Accounting at Essex (1998-2004), where he focused on auditing and financial standards. His advanced education has solidified his position as a leading expert in accounting research and education.

💼 Experience

Dr. Dedoulis has had a robust academic career, teaching financial accounting at both undergraduate and postgraduate levels at AUEB since 2006. Additionally, he has worked as a certified auditor between 2005 and 2009, providing him with practical insights that complement his academic work. He has also been a reviewer for prominent journals in the field, contributing to the academic community’s understanding of accounting and auditing issues. Dr. Dedoulis’s diverse experience enhances his ability to deliver expert guidance to students and practitioners alike.

Honors & Awards 🏆🎓

Throughout his career, Dr. Dedoulis has received multiple recognitions for his scholarly contributions. He is a respected reviewer for leading journals such as Critical Perspectives on Accounting and Journal of Business Ethics. Additionally, his professional experience as a certified auditor and his involvement in the Committee of Accounting Books of the Ministry of Economy highlight his standing in both academic and professional circles. His continued influence in accounting research demonstrates his significant impact on the field.

Research Focus 🔬⚡

Dr. Dedoulis’s research spans auditing, ethics, and accounting standards, focusing on how these domains evolve and their societal implications. He explores the development of auditing practices, the role of ethics in accounting, and the intersection of accounting standards with inequalities. His work is published in top journals, reflecting his expertise in the intersection of finance, ethics, and institutional developments in accounting. His contributions aim to influence both policy and practice in accounting and auditing.

Conclusion

Dr. Dedoulis is a highly deserving candidate for the Best Researcher Award, given his sustained excellence in research, teaching, and academic service. His work continues to shape the field of accounting, particularly in corporate governance and social responsibility. The recognition of his contributions in leading journals and conferences highlights his scholarly influence. Moving forward, diversifying his research and engaging more with the public and industry would further elevate his impact.

 

Publication Top Notes 📚

 

Corporate social responsibility reporting and organizational stigma: The case of “sin” industries
Authors: V Grougiou, E Dedoulis, S Leventis
Journal: Journal of Business Research
Citations: 323
Year: 2016

Corporate social responsibility and earnings management in US banks
Authors: V Grougiou, S Leventis, E Dedoulis, S Owusu-Ansah
Journal: Accounting Forum
Citations: 284
Year: 2014

The impact of religiosity on audit pricing
Authors: S Leventis, E Dedoulis, O Abdelsalam
Journal: Journal of Business Ethics
Citations: 126
Year: 2018

The impact of religiosity and corruption on CSR reporting: The case of US banks
Authors: A Chantziaras, E Dedoulis, V Grougiou, S Leventis
Journal: Journal of Business Research
Citations: 113
Year: 2020

Managing the European football industry: UEFA’s regulatory intervention and the impact on accounting quality
Authors: P Dimitropoulos, S Leventis, E Dedoulis
Journal: European Sport Management Quarterly
Citations: 110
Year: 2016

The cost of sin: The effect of social norms on audit pricing
Authors: S Leventis, I Hasan, E Dedoulis
Journal: International Review of Financial Analysis
Citations: 89
Year: 2013

Transplanting Anglo-American accounting oversight boards to a diverse institutional context
Authors: C Caramanis, E Dedoulis, S Leventis
Journal: Accounting, Organizations and Society
Citations: 72
Year: 2015

Corporate governance and institutions-A review and research agenda
Authors: A Zattoni, E Dedoulis, S Leventis, H Van Ees
Journal: Corporate Governance – An International Review
Citations: 62
Year: 2020

Equality, diversity and inclusion in accounting
Authors: O Kyriakidou, O Kyriacou, M Özbilgin, E Dedoulis
Journal: Critical Perspectives on Accounting
Citations: 60
Year: 2016

Imperialism of influence and the state–profession relationship: The formation of the Greek auditing profession in the post-WWII era
Authors: E Dedoulis, C Caramanis
Journal: Critical Perspectives on Accounting
Citations: 60
Year: 2007

 

 

Mudit Kumar | Pharmacology | Best Researcher Award

Published on by Global Academic Awards

Mr. Mudit Kumar | Pharmacology | Best Researcher Award

Assistant professor at Faculty of Pharmacy, Uttar Pradesh University of Medical Sciences Saifai Etawah Uttar pradesh, India

Mr. Mudit Kumar, an Assistant Professor in Pharmacology and Pharmacy at Uttar Pradesh University of Medical Sciences (UPUMS), has an impressive academic and research background. With a decade-long teaching career and multiple high-impact publications, patents, and awards, he has demonstrated consistent dedication to advancing pharmaceutical sciences. His contributions span research, innovation, and community involvement, making him a strong contender for the Best Researcher Award.

Professional Profile

Google Scholar  

Orcid

Scopus

🎓 Education

Mr. Mudit Kumar’s educational journey reflects his dedication to pharmaceutical sciences. He earned his Bachelor of Pharmacy (B.Pharm) in 2009 from Uttar Pradesh Technical University, establishing a solid foundation in pharmaceutical principles. Continuing his academic pursuits, he completed his Master of Pharmacy (M.Pharm) in 2012 from Bhagwant University, specializing in pharmacology. His postgraduate education equipped him with advanced knowledge of drug development, therapeutic mechanisms, and pharmacokinetics. Currently, Mr. Kumar is pursuing his PhD in Pharmacology, further delving into innovative pharmaceutical research. His academic progression demonstrates a commitment to continuous learning and specialization. Throughout his studies, he has shown a keen interest in pharmacological research, nanotechnology, and herbal medicine. His educational achievements have laid the groundwork for his successful teaching and research career, enabling him to contribute meaningfully to academia and the pharmaceutical industry.

💼 Experience

Mr. Mudit Kumar has over a decade of teaching experience in pharmacology and pharmacy. Since 2015, he has been serving as an Assistant Professor at the Uttar Pradesh University of Medical Sciences (UPUMS), Saifai, Etawah. In this role, he imparts knowledge in pharmaceutical sciences, mentors students, and contributes to curriculum development. Beyond teaching, Mr. Kumar actively engages in various institutional committees, including the Sports Committee, NIRF & NAAC Committee, and Career Guidance Committee, demonstrating his commitment to holistic academic growth. He has also played a role in maintaining student welfare as a member of the Anti-Ragging Squad. His experience extends to research and innovation, where he collaborates on projects leading to patents and publications. His professional journey underscores a blend of education, mentorship, and institutional service, contributing significantly to the academic and professional development of his students and colleagues.

Honors & Awards 🏆🎓

Mr. Mudit Kumar’s dedication to pharmaceutical sciences has earned him several prestigious accolades. In 2024, he received the Academic Excellence Award from the InSc Institute of Scholar for his outstanding contributions to research and teaching. The same year, he was recognized as the Best Pharmaceutical Scientist of the Year by the Preethvi Abhyuday Educators Association, highlighting his impactful work in pharmacology and drug development. These honors reflect his commitment to excellence, innovation, and advancing pharmaceutical education. Additionally, Mr. Kumar holds a lifetime professional membership with InSc and is an active member of the Association of Pharmaceutical Teachers of India (APTI) since 2023. His involvement in professional bodies and consistent recognition for academic and research achievements underline his stature as a leading figure in the pharmaceutical field. These awards serve as a testament to his dedication and influence in academia and research.

Research Focus 🔬⚡

Mr. Mudit Kumar’s research focuses on pharmacology, nanotechnology, and herbal medicine. He is particularly interested in the development of innovative drug delivery systems, such as lipid-polymer hybrid nanosystems and nano-lipid herbal formulations for diseases like diabetes and cancer. His work also explores the nephroprotective potential of natural extracts, wound healing properties of medicinal plants, and therapeutic approaches for Alzheimer’s disease. Additionally, Mr. Kumar investigates adverse drug reactions and the role of artificial intelligence in clinical trials. His research contributions include several peer-reviewed publications and three patents, showcasing his commitment to blending traditional medicine with modern pharmaceutical technologies. His interdisciplinary approach aims to enhance therapeutic efficacy and patient safety. Through his research, Mr. Kumar strives to bridge the gap between traditional herbal remedies and cutting-edge pharmaceutical innovations to address critical healthcare challenges.

Conclusion

Mr. Mudit Kumar’s extensive research portfolio, innovative patents, and commitment to education position him as a deserving candidate for the Best Researcher Award. His work not only advances pharmaceutical knowledge but also bridges the gap between research and real-world applications.

 

Publication Top Notes 📚

📘 Callistemon citrinus (bottle brush) an important medicinal plant: a review of its traditional uses, phytoconstituents and pharmacological properties
Authors: N Sutar, R Sutar, M Kumar
Citations: 17
Year: 2014

🧪 Lipid–polymer hybrid nanosystems: a rational fusion for advanced therapeutic delivery
Authors: S Jain, M Kumar, P Kumar, J Verma, JM Rosenholm, KK Bansal, A Vaidya
Citations: 13
Year: 2023

🥒 Genetic analysis of yield traits in snake gourd (Trichosanthes anguina L.) genotypes
Authors: MJ Kumar, GK Rekha, CV Ramana, A Rajani, DR Suneetha
Citations: 2
Year: 2024

💊 Comparison between hypolipidemic effect of Lagenaria siceraria and lovastatin in hypercholesterolemic rats
Authors: A Senior, S Kumar, M Kumar
Citations: 2
Year: 2019

🏭 Sickness in small-scale industries in India
Authors: RR Saini, P Kumar, M Kumar
Citations: 2
Year: 2004

🍄 Current therapy and protective potential of medicinal mushroom Cordyceps militaris against Alzheimer’s disease
Authors: S Thakur, Y Singh, P Goyal, M Kumar
Citations: 1
Year: 2022

🧬 Analytical methods in the detection of proteins and peptides in tissue fluids and homogenates
Authors: S Jain, P Kumar, M Kumar, A Vaidya
Year: 2024

📚 Handbook of Blood Brain Barrier, Peptides and Amino Acids
Authors: Mudit Kumar, Dr. Pushpendra Kumar
Year: 2022

🌿 Anti-diabetic agent from nature
Author: Mudit Kumar
Year: 2018

📏 Common fixed point theorems satisfying a contractive condition of integral type in ε-chainable fuzzy metric space
Authors: RK Saini, B Singh, M Kumar, A Sharma
Year: N/A

🤖 AI in clinical trials and drug development: Challenges and potential advancements
Authors: D Gupta, P Wal, A Wal, KR Sribhavani, M Kumar, KC Panda, MC Sharma
Year: N/A

🩹 Evaluation of wound healing activity
Author: M Kumar
Year: N/A

🍃 Evaluation of Trichosanthes dioica Roxb. extract for nephroprotective potential
Authors: M Kumar, P Kumar, M Piplani
Year: N/A

 

 

Divya Jain | Pharmacology Award | Women Researcher Award

Published on by Global Academic Awards

Dr. Divya Jain | Pharmacology Award | Women Researcher Award

Dr. Divya Jain, Uttaranchal University, India

Dr. Divya Jain is an accomplished microbiologist, holding a Ph.D. in Microbiology from Banasthali Vidyapith, Rajasthan (2023), an M.Sc. in Microbiology from Graphic Era University, Dehradun (2018), and a B.Sc. in Biotechnology from Banasthali Vidyapith (2016). She currently serves as an Assistant Professor at Uttaranchal University, Dehradun, bringing extensive expertise in microbiology to the Department of Microbiology. Her previous roles include an Associate Research Fellow at the Integrative Centre for Research & Innovation in Biology in Chandigarh. Dr. Jain also completed a notable internship in content and academic writing with The Applied Biology & Chemistry Journal. 📚🔬✨

Publication profile

Orcid

Google Scholar

🎓 Education

Dr. Divya Jain holds a Ph.D. in Microbiology from Banasthali Vidyapith, Rajasthan (2023), an M.Sc. in Microbiology from Graphic Era University, Dehradun (2018), and a B.Sc. in Biotechnology from Banasthali Vidyapith (2016). She completed her high school education in PCB from S.D.R.R Public School, Shamli (2013). 📘🔬

🏢 Work Experience

Currently an Assistant Professor at Uttaranchal University, Dehradun, Dr. Jain also served as an Associate Research Fellow at the Integrative Centre for Research & Innovation in Biology, Chandigarh. 📚🔬

🏅 Certificates and Awards

Dr. Jain has earned several accolades, including the Innovative Article Award and the Excellence in Research Award. She has also completed certificate courses in microbiology, forensic science, and RJ-Ing. 🏆📜

 

Research Focus 🔬🌍

Dr. Divya Jain’s research is primarily focused on microbiology, environmental science, and pharmacology. Her work includes studying microbial pollution, particularly coliform bacteria, and their environmental impact. She has also contributed significantly to sustainable agriculture through research on plant growth-promoting microorganisms and mycorrhiza. Dr. Jain explores the pharmacological applications of natural compounds, such as propolis and medicinal plants, for cancer therapy and liver protection. Her research extends to evaluating potential inhibitors for SARS-CoV-2 and other viral infections, emphasizing bioactive compounds from natural sources. Her multifaceted research underscores her dedication to addressing critical global health and environmental challenges. 🌱🧬🧪

 

Publication Top Notes

  • “Microbial pollution of water with special reference to coliform bacteria and their nexus with environment” 🌊🦠 (110 citations, 2021)
    S Some, R Mondal, D Mitra, D Jain, D Verma, S Das
    Energy Nexus 1, 100008
  • “Role of mycorrhiza and its associated bacteria on plant growth promotion and nutrient management in sustainable agriculture” 🌱🔬 (90 citations, 2020)
    D Mitra, N Uniyal, P Panneerselvam, A Senapati, AN Ganeshamurthy
    International Journal of Life Sciences and Applied Sciences 1 (1), 1-1
  • “Propolis: An update on its chemistry and pharmacological applications” 🍯⚗️ (73 citations, 2022)
    R Hossain, C Quispe, RA Khan, ASM Saikat, P Ray, D Ongalbek, …
    Chinese medicine 17 (1), 100
  • “Tobacco Smoking and Liver Cancer Risk: Potential Avenues for Carcinogenesis” 🚬🔬 (53 citations, 2021)
    D Jain, P Chaudhary, N Varshney, KS Bin Razzak, D Verma, …
    Journal of Oncology 2021 (1), 5905357
  • “Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PLpro and Mpro/3CLpro: molecular docking and simulation studies of three pertinent medicinal plant natural components” 🧬🌿 (44 citations, 2021)
    D Verma, D Mitra, M Paul, P Chaudhary, A Kamboj, H Thatoi, P Janmeda, …
    Current Research in Pharmacology and Drug Discovery 2, 100038
  • “Biosynthesis of secondary metabolites based on the regulation of microRNAs” 🧬🧪 (33 citations, 2022)
    R Hossain, C Quispe, ASM Saikat, D Jain, A Habib, P Janmeda, MT Islam, …
    BioMed Research International 2022 (1), 9349897
  • “Hepatoprotective activity of medicinal plants: A mini review” 🌿🛡️ (29 citations, 2020)
    D Jain, P Chaudhary, A Kotnala, R Hossain, K Bisht, MN Hossain
    Journal of Medicinal Plants Studies 8 (5), 183-188
  • “Quercetin and/or Ascorbic Acid Modulatory Effect on Phenobarbital-Induced Sleeping Mice Possibly through GABAA and GABAB Receptor Interaction Pathway” 💤🍊 (25 citations, 2021)
    R Hossain, K Al-Khafaji, RA Khan, C Sarkar, MS Islam, D Dey, D Jain, …
    Pharmaceuticals 14 (8), 721
  • “Anticancer effects of acteoside: Mechanistic insights and therapeutic status” 🧬🎗️ (22 citations, 2022)
    RA Khan, R Hossain, P Roy, D Jain, ASM Saikat, APR Shuvo, M Akram, …
    European Journal of Pharmacology 916, 174699
  • “Carcinogenic effects of N-nitroso compounds in environment” 🚫🦠 (22 citations, 2020)
    D Jain, P Chaudhary, N Varshney, P Janmeda
    Environment Conservation Journal 21 (3), 25-41